+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmaceutical Contract Manufacturing & Research Services Market Research Report by Service, by End-user, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 5454990
  • Report
  • January 2022
  • Region: Global
  • 211 Pages
  • 360iResearch™
UP TO OFF
until Dec 31st 2022

FEATURED COMPANIES

  • AbbVie, Inc.
  • Aenova Holding GmbH
  • Boehringer Ingelheim GmbH
  • Catalent Pharma Solutions
  • Covance, Inc.
  • Grifols S.A
The Global Pharmaceutical Contract Manufacturing & Research Services Market size was estimated at USD 174.41 billion in 2020, is expected to reach USD 185.52 billion in 2021, and is projected to grow at a CAGR of 6.73% to reach USD 275.26 billion by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Pharmaceutical Contract Manufacturing & Research Services to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Service, the market was studied across Manufacturing and Research. The Manufacturing is further studied across Advanced Drug Delivery Formulations Packaging, API/Bulk Drugs, Finished Dose Formulations, and Packaging. The Finished Dose Formulations is further studied across Liquid Formulations, Semi-solid Formulations, and Solid Formulations. The Research is further studied across Cardiology, Inflammation & Immunology, Neuroscience, Oncology, and Vaccines.
  • Based on End-user, the market was studied across Big Pharma, Generic Pharmaceutical Companies, and Small & Mid-Size Pharma.
  • Based on Region, the market was studied across the Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Ongoing research by the publisher amplifies their research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharmaceutical Contract Manufacturing & Research Services Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pharmaceutical Contract Manufacturing & Research Services Market, including AbbVie, Inc., Aenova Holding GmbH, Albany Molecular Research, Inc., Baxter BioPharma Solutions, Boehringer Ingelheim GmbH, Catalent Pharma Solutions, Charles River Laboratories International, Inc., Covance, Inc., Famar Health Care Services, Grifols S.A, Jubilant Life Sciences Limited, Ligand Pharmaceuticals, Inc., Lonza, Pfizer, Inc., Pharmaceutical Product Development, LLC, QuintilesIMS, Recipharm AB., Valeant Pharmaceuticals International Inc., Vetter Pharma, and West Pharmaceutical Services, Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Pharmaceutical Contract Manufacturing & Research Services Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmaceutical Contract Manufacturing & Research Services Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmaceutical Contract Manufacturing & Research Services Market?
4. What is the competitive strategic window for opportunities in the Global Pharmaceutical Contract Manufacturing & Research Services Market?
5. What are the technology trends and regulatory frameworks in the Global Pharmaceutical Contract Manufacturing & Research Services Market?
6. What is the market share of the leading vendors in the Global Pharmaceutical Contract Manufacturing & Research Services Market?
7. What modes and strategic moves are considered suitable for entering the Global Pharmaceutical Contract Manufacturing & Research Services Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie, Inc.
  • Aenova Holding GmbH
  • Boehringer Ingelheim GmbH
  • Catalent Pharma Solutions
  • Covance, Inc.
  • Grifols S.A
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing number of CDMOs and rising investments in advanced manufacturing technologies by CDMOs
5.1.1.2. Rising investments in drug development & discovery and advanced manufacturing technologies
5.1.1.3. Growing outsourcing volume by big pharmaceutical companies
5.1.2. Restraints
5.1.2.1. Regulatory pressure on contract research organization services
5.1.3. Opportunities
5.1.3.1. Growing demand for specialized testing services
5.1.3.2. Increase in focus of biosimilars and generics
5.1.3.3. Growing demand for cell and gene therapies for targeted treatment
5.1.4. Challenges
5.1.4.1. Variable trade policies between countries
5.2. Cumulative Impact of COVID-19

6. Pharmaceutical Contract Manufacturing & Research Services Market, by Service
6.1. Introduction
6.2. Manufacturing
6.2.1. Advanced Drug Delivery Formulations Packaging
6.2.2. API/Bulk Drugs
6.2.3. Finished Dose Formulations
6.2.3.1. Liquid Formulations
6.2.3.2. Semi-solid Formulations
6.2.3.3. Solid Formulations
6.2.4. Packaging
6.3. Research
6.3.1. Cardiology
6.3.2. Inflammation & Immunology
6.3.3. Neuroscience
6.3.4. Oncology
6.3.5. Vaccines

7. Pharmaceutical Contract Manufacturing & Research Services Market, by End-user
7.1. Introduction
7.2. Big Pharma
7.3. Generic Pharmaceutical Companies
7.4. Small & Mid-Size Pharma

8. Americas Pharmaceutical Contract Manufacturing & Research Services Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Pharmaceutical Contract Manufacturing & Research Services Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand

10. Europe, Middle East & Africa Pharmaceutical Contract Manufacturing & Research Services Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. AbbVie, Inc.
12.2. Aenova Holding GmbH
12.3. Albany Molecular Research, Inc.
12.4. Baxter BioPharma Solutions
12.5. Boehringer Ingelheim GmbH
12.6. Catalent Pharma Solutions
12.7. Charles River Laboratories International, Inc.
12.8. Covance, Inc.
12.9. Famar Health Care Services
12.10. Grifols S.A
12.11. Jubilant Life Sciences Limited
12.12. Ligand Pharmaceuticals, Inc.
12.13. Lonza
12.14. Pfizer, Inc.
12.15. Pharmaceutical Product Development, LLC
12.16. QuintilesIMS
12.17. Recipharm AB.
12.18. Valeant Pharmaceuticals International Inc.
12.19. Vetter Pharma
12.20. West Pharmaceutical Services, Inc.

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing


List of Figures
Figure 1. Global Pharmaceutical Contract Manufacturing & Research Services Market: Research Process
Figure 2. Global Pharmaceutical Contract Manufacturing & Research Services Market: Market Dynamics
Figure 3. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Service, 2020 Vs 2027 (%)
Figure 4. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Service, 2020 Vs 2027 (USD Billion)
Figure 5. Competitive Strategic Window For Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Service, 2027
Figure 6. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Manufacturing, 2018-2027 (USD Billion)
Figure 7. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Manufacturing, by Region, 2020 Vs 2027 (USD Billion)
Figure 8. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Advanced Drug Delivery Formulations Packaging, 2018-2027 (USD Billion)
Figure 9. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Advanced Drug Delivery Formulations Packaging, by Region, 2020 Vs 2027 (USD Billion)
Figure 10. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Api/Bulk Drugs, 2018-2027 (USD Billion)
Figure 11. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Api/Bulk Drugs, by Region, 2020 Vs 2027 (USD Billion)
Figure 12. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Finished Dose Formulations, 2018-2027 (USD Billion)
Figure 13. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Finished Dose Formulations, by Region, 2020 Vs 2027 (USD Billion)
Figure 14. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Liquid Formulations, 2018-2027 (USD Billion)
Figure 15. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Liquid Formulations, by Region, 2020 Vs 2027 (USD Billion)
Figure 16. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Semi-Solid Formulations, 2018-2027 (USD Billion)
Figure 17. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Semi-Solid Formulations, by Region, 2020 Vs 2027 (USD Billion)
Figure 18. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Solid Formulations, 2018-2027 (USD Billion)
Figure 19. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Solid Formulations, by Region, 2020 Vs 2027 (USD Billion)
Figure 20. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Packaging, 2018-2027 (USD Billion)
Figure 21. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Packaging, by Region, 2020 Vs 2027 (USD Billion)
Figure 22. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Research, 2018-2027 (USD Billion)
Figure 23. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Research, by Region, 2020 Vs 2027 (USD Billion)
Figure 24. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Cardiology, 2018-2027 (USD Billion)
Figure 25. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Cardiology, by Region, 2020 Vs 2027 (USD Billion)
Figure 26. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Inflammation & Immunology, 2018-2027 (USD Billion)
Figure 27. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Inflammation & Immunology, by Region, 2020 Vs 2027 (USD Billion)
Figure 28. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Neuroscience, 2018-2027 (USD Billion)
Figure 29. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Neuroscience, by Region, 2020 Vs 2027 (USD Billion)
Figure 30. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Oncology, 2018-2027 (USD Billion)
Figure 31. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Oncology, by Region, 2020 Vs 2027 (USD Billion)
Figure 32. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Vaccines, 2018-2027 (USD Billion)
Figure 33. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Vaccines, by Region, 2020 Vs 2027 (USD Billion)
Figure 34. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by End-User, 2020 Vs 2027 (%)
Figure 35. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by End-User, 2020 Vs 2027 (USD Billion)
Figure 36. Competitive Strategic Window For Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by End-User, 2027
Figure 37. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Big Pharma, 2018-2027 (USD Billion)
Figure 38. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Big Pharma, by Region, 2020 Vs 2027 (USD Billion)
Figure 39. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Generic Pharmaceutical Companies, 2018-2027 (USD Billion)
Figure 40. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Generic Pharmaceutical Companies, by Region, 2020 Vs 2027 (USD Billion)
Figure 41. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Small & Mid-Size Pharma, 2018-2027 (USD Billion)
Figure 42. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Small & Mid-Size Pharma, by Region, 2020 Vs 2027 (USD Billion)
Figure 43. Americas Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 44. Argentina Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 45. Brazil Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 46. Canada Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 47. Mexico Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 48. United States Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 49. Asia-Pacific Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 50. Australia Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 51. China Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 52. India Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 53. Indonesia Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 54. Japan Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 55. Malaysia Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 56. Philippines Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 57. Singapore Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 58. South Korea Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 59. Taiwan Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 60. Thailand Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 61. Europe, Middle East & Africa Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 62. France Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 63. Germany Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 64. Italy Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 65. Netherlands Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 66. Qatar Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 67. Russia Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 68. Saudi Arabia Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 69. South Africa Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 70. Spain Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 71. United Arab Emirates Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 72. United Kingdom Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Figure 73. Global Pharmaceutical Contract Manufacturing & Research Services Market: Fpnv Positioning Matrix
Figure 74. Global Pharmaceutical Contract Manufacturing & Research Services Market: Share, by Key Player, 2020
Figure 75. Competitive Scenario Analysis In Global Pharmaceutical Contract Manufacturing & Research Services Market, by Type


List of Tables
Table 1. Global Pharmaceutical Contract Manufacturing & Research Services Market: Market Segmentation & Coverage
Table 2. United States Dollar Exchange Rate, 2016-2020
Table 3. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Service, 2018-2027 (USD Billion)
Table 4. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Manufacturing, by Region, 2018-2027 (USD Billion)
Table 5. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Advanced Drug Delivery Formulations Packaging, by Region, 2018-2027 (USD Billion)
Table 6. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Api/Bulk Drugs, by Region, 2018-2027 (USD Billion)
Table 7. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Finished Dose Formulations, by Region, 2018-2027 (USD Billion)
Table 8. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Liquid Formulations, by Region, 2018-2027 (USD Billion)
Table 9. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Semi-Solid Formulations, by Region, 2018-2027 (USD Billion)
Table 10. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Solid Formulations, by Region, 2018-2027 (USD Billion)
Table 11. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Packaging, by Region, 2018-2027 (USD Billion)
Table 12. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Research, by Region, 2018-2027 (USD Billion)
Table 13. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Cardiology, by Region, 2018-2027 (USD Billion)
Table 14. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Inflammation & Immunology, by Region, 2018-2027 (USD Billion)
Table 15. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Neuroscience, by Region, 2018-2027 (USD Billion)
Table 16. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Oncology, by Region, 2018-2027 (USD Billion)
Table 17. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Vaccines, by Region, 2018-2027 (USD Billion)
Table 18. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by End-User, 2018-2027 (USD Billion)
Table 19. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Big Pharma, by Region, 2018-2027 (USD Billion)
Table 20. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Generic Pharmaceutical Companies, by Region, 2018-2027 (USD Billion)
Table 21. Global Pharmaceutical Contract Manufacturing & Research Services Market Size, by Small & Mid-Size Pharma, by Region, 2018-2027 (USD Billion)
Table 22. Americas Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 23. Argentina Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 24. Brazil Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 25. Canada Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 26. Mexico Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 27. United States Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 28. Asia-Pacific Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 29. Australia Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 30. China Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 31. India Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 32. Indonesia Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 33. Japan Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 34. Malaysia Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 35. Philippines Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 36. Singapore Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 37. South Korea Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 38. Taiwan Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 39. Thailand Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 40. Europe, Middle East & Africa Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 41. France Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 42. Germany Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 43. Italy Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 44. Netherlands Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 45. Qatar Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 46. Russia Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 47. Saudi Arabia Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 48. South Africa Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 49. Spain Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 50. United Arab Emirates Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 51. United Kingdom Pharmaceutical Contract Manufacturing & Research Services Market Size, 2018-2027 (USD Billion)
Table 52. Global Pharmaceutical Contract Manufacturing & Research Services Market: Scores
Table 53. Global Pharmaceutical Contract Manufacturing & Research Services Market: Business Strategy
Table 54. Global Pharmaceutical Contract Manufacturing & Research Services Market: Product Satisfaction
Table 55. Global Pharmaceutical Contract Manufacturing & Research Services Market: Ranking
Table 56. Global Pharmaceutical Contract Manufacturing & Research Services Market: Share, by Key Player, 2020
Table 57. Global Pharmaceutical Contract Manufacturing & Research Services Market: Merger & Acquisition
Table 58. Global Pharmaceutical Contract Manufacturing & Research Services Market: Agreement, Collaboration, & Partnership
Table 59. Global Pharmaceutical Contract Manufacturing & Research Services Market: New Product Launch & Enhancement
Table 60. Global Pharmaceutical Contract Manufacturing & Research Services Market: Investment & Funding
Table 61. Global Pharmaceutical Contract Manufacturing & Research Services Market: Award, Recognition, & Expansion
Table 62. Global Pharmaceutical Contract Manufacturing & Research Services Market: License & Pricing
Note: Product cover images may vary from those shown
  • AbbVie, Inc.
  • Aenova Holding GmbH
  • Albany Molecular Research, Inc.
  • Baxter BioPharma Solutions
  • Boehringer Ingelheim GmbH
  • Catalent Pharma Solutions
  • Charles River Laboratories International, Inc.
  • Covance, Inc.
  • Famar Health Care Services
  • Grifols S.A
  • Jubilant Life Sciences Limited
  • Ligand Pharmaceuticals, Inc.
  • Lonza
  • Pfizer, Inc.
  • Pharmaceutical Product Development, LLC
  • QuintilesIMS
  • Recipharm AB.
  • Valeant Pharmaceuticals International Inc.
  • Vetter Pharma
  • West Pharmaceutical Services, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...